Darwin Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-14,327
Closed -$298K 148
2023
Q1
$298K Buy
14,327
+115
+0.8% +$2.31K 0.08% 125
2022
Q4
$290K Buy
+14,212
New +$295K 0.08% 142

Other funds holding BTAL

Darwin Wealth Management's BTAL Position: Q2 2023 in Review

Darwin Wealth Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2023, closing a stake of 14,327 shares — an estimated $298K sold.

Darwin Wealth Management first reported a position in BTAL in Q4 2022 and held it in 2 quarters. The position peaked at $298K in Q1 2023. 72 funds tracked by Wall St. Rank hold BTAL as of Q2 2023.

  • Darwin Wealth Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2023 after selling out during the quarter.
  • Darwin Wealth Management sold 14,327 AGF US Market Neutral Anti-Beta Fund shares in Q2 2023, an estimated $298K.
  • Darwin Wealth Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2022 and held it in 2 quarters.
  • Darwin Wealth Management's AGF US Market Neutral Anti-Beta Fund position peaked at $298K in Q1 2023.
  • 72 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2023.

Based on Darwin Wealth Management's 13F filing for Q2 2023, filed 12 Jul 2023.